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Abstract. Cellular disintegrins are a family of proteins 
that are related to snake venom integrin ligands and 
metalloproteases. We have cloned and sequenced the 
mouse and human homologue of a widely expressed 
cellular disintegrin, which we have termed MDC9 (for 
metalloprotease/disintegrin/cysteine-rich protein 9). 
The deduced mouse and human protein sequences are 
82% identical. MDC9 contains several distinct protein 
domains: a signal sequence is followed by a prodomain 
and a domain with sequence similarity to snake venom 
metalloproteases, a disintegrin domain, a cysteine-rich 
region, an EGF repeat, a membrane anchor, and a cyto- 
plasmic tail. The cytoplasmic tail of MDC9 has two pro- 
line-rich sequences which can bind the SH3 domain of 
Src, and may therefore function as SH3 ligand domains. 
Western blot analysis shows that MDC9 is an ~84-kD 
glycoprotein in all mouse tissues examined, and in NIH 
3T3 fibroblast and C2C12 myoblast mouse cell lines. 
MDC9 can be both cell surface biotinylated and 1251- 
labeled in NIH 3T3 mouse fibroblasts, indicating that 
the protein is present on the plasma membrane. Ex- 
pression of MDC9 in COS-7 cells yields an 84-kD pro- 
tein, and immunofluorescence analysis of COS-7 cells 
expressing MDC9 shows a staining pattern that is con- 
sistent with a plasma membrane localization. The ap- 
parent molecular mass of 84 kD suggests that MDC9 
contains a membrane-anchored metaUoprotease and 
disintegrin domain. We propose that MDC9 might 
function as a membrane-anchored integrin ligand or 
metalloprotease, or that MDC9 may combine both ac- 
tivities in one protein. 
C 
ELLULAR disintegrins are a family of proteins that 
are related to snake venom disintegrins and metal- 
loproteases. Disintegrins were first isolated from 
snake venom as short soluble peptides that bind with high 
affinity to the platelet integrin gpIIb/IIIa, thereby compet- 
itively inhibiting platelet aggregation (14, 17, 18, 23, 28, 37). 
The first recognized cellular disintegrin was the guinea pig 
sperm protein fertilin (previously referred to as PH-30), 
which mediates sperm-egg membrane binding and fusion 
(7, 8, 29, 35, 43). Additional cellular disintegrin sequences 
have been reported in the mouse (41), in mouse mono- 
cytes (49), as potential myoblast fusion protein (48), in rat 
and monkey epididymal epithelial cells (34),  and in testis 
of different species (4, 16, 32-34, 46). Another cellular dis- 
integrin was reported as a potential breast cancer tumor 
suppressor (11), and more partial and complete sequences 
have been deposited in the GenBank database (45).  The 
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family of known cellular disintegrins thus continues to ex- 
pand. 
Currently, the best characterized member of this protein 
family is the sperm-surface protein fertilin, which has been 
implicated in  sperm-egg  membrane binding and  fusion. 
Fertilin is an integral membrane complex of two distinct 
cellular disintegrins, c~ and [3 (7, 8, 44), that are both made 
as larger precursors, and are processed at different stages 
of sperm maturation. The a subunit of fertilin is processed 
in the testis, and fertilin [3 is processed in the epididymis, 
where its cleavage correlates with the acquisition of fertil- 
ization competence in epidydimal sperm (7).  Guinea pig 
sperm-egg membrane fusion can be inhibited by a mono- 
clonal antibody against fertilin (35),  as well as with pep- 
tides corresponding to the predicted fertilin integrin-bind- 
ing domain (29),  and mouse fertilin most likely binds to 
the a6131 integrin on mouse eggs (3). 
The known functions of fertilin and snake venom disin- 
tegrins raise intriguing ideas about the possible physiologi- 
cal  role  of  the  newly  discovered  cellular  disintegrins. 
Snake venom disintegrins are high-affinity integrin ligands, 
and there is substantial evidence that fertilin is also an in- 
tegrin ligand. Integrins (1,  19, 20, 36) are found on virtu- 
ally every cell type, and mediate a variety of cell-cell and 
cell-matrix interactions. If other cellular disintegrins are 
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some of these processes. 
Here we report the cloning and cDNA sequencing, and 
the  initial  biochemical  characterization  of  a  widely  ex- 
pressed cellular disintegrin referred to as metalloprotease/ 
disintegrin/cysteine-rich protein 9 (MDC9)J MDC9 is highly 
conserved between mouse and human, containing all pro- 
tein domains that are found in other cellular disintegrins, 
and also includes a proline-rich cytoplasmic tail that may 
function as an Src homology 3 ligand domain. The appar- 
ent molecular mass of 84 kD in all tissues and cells exam- 
ined  suggests  that  mouse  MDC9  contains  a  membrane- 
anchored metalloprotease and disintegrin  domain. These 
results are discussed in the context of the predicted role of 
MDC9 in cell-cell interactions. 
Materials and Methods 
Animals and Reagents 
Reagents, including  Taq  polymerase, were  obtained  from  Boehringer 
Mannheim (Indianapolis, IN), unless indicated otherwise. Mice (nontrans- 
genic animals) were obtained from the transgenic breeding facility of the 
Sloan Kettering Institute (New York, NY). Rabbits were purchased from 
Hazelton (Denver, PA). Radiolabeled nucleotides were supplied by Am- 
ersham Corp. (Arlington Heights, IL). 
cDNA Cloning 
A  sequence tag encoding the partial  disintegrin domain of MDC9 (se- 
quence tag No. 16-2 (41)) was used to screen a mouse lung cDNA library 
(Stratagene, La Jolla, CA) under high stringency conditions as describel~i 
(8), which yielded three identical  clones with inserts of 2,330 bp.  One 
cDNA  clone  was  sequenced completely  (Sequenase,  USB,  Cleveland, 
OH) in both orientations by a primer walk. Since the cDNA insert size of 
2.33  kb did not match that observed for the mRNA (~4 kb), we  con- 
structed a new mouse lung cDNA library (Stratagene ZAP cDNA library 
synthesis kit, according to the manufacturer's instructions, see also refer- 
ence 24). The unamplified cDNA library was screened under high strin- 
gency conditions with the partial 2.33 kb MDC9 clone, and yielded more 
than 100 positive plaques in the primary" screen. PCR analysis of 80 posi- 
tive plaques with an antisense primer that annealed close to the 5' end of 
the 2.33  kb clone, and the vector specific T3 primer, revealed that the 
cDNA of 10 clones extended between 800 and 850 bp past the 5' end of 
the shorter 2.33 kb clone. One cDNA clone was purified, subjected to in 
vitro excision, and sequenced as described above. This clone contained a 
cDNA insert of 3,851  bp, encoding for  an open reading frame of 845 
amino acid residues (GenBank accession No. U41765). 
To clone the full-length cDNA for human MDC9, we synthesized a hu- 
man cDNA library from MDA-MB-468 mammary epithelial carcinoma 
cells (ATCC HTB-132) as described above. The MDA-MB-468 cDNA li- 
brary was screened with the full-length cDNA of mouse MDC9, and more 
than 50 positive plaques were identified. Clones with the longest 5' exten- 
sion were identified by PCR, (see above), using as antisense primer the 
most 5' sequence of a  partial human MDC9 sequence (GenBank acces- 
sion No.  D14665).  One clone with a  cDNA insert of 3,866 bp was se- 
quenced on both strands, and contained an open reading frame of 819 
amino acid residues (GenBank accession No. U41766). cDNA- and trans- 
lated-protein sequences were analyzed using MacVector software (Kodak 
IBI, New Haven, CT). Sequence alignments and comparisons among cel- 
lular disintegrin proteins was performed using DNA STAR MEGALIGN 
software. 
Northern Blot 
Total RNA was isolated from mouse lung, heart, liver, lung, skeletal mus- 
cle, brain, spleen, kidney and testis, and from C2C12 mouse muscle cells 
1. Abbreviations  used  in  this paper:  MDC9, metalloprotease/disintegrin/ 
cysteine-rich protein 9; SH3, Src homology 3. 
as described (9). For each tissue, 15 txg of RNA were run per lane, and the 
integrity of the ribosomal RNA of each sample was monitored on a sepa- 
rate gel. Human tissue Northern blots were obtained from Clontech (Palo 
Alto, CA). Northern blot  analysis was performed with the appropriate 
32p-labeled mouse or human MDC9 cDNA probe under high stringency 
as previously described (41). 
Blot Overlay with Biotinylated SH3 Domains 
of Src and Abl 
Three separate gst-fusion proteins containing different portions of the 
mouse MDC9 cytoplasmic tail were constructed by PCR using gene-spe- 
cific primers with added restriction sites to allow direct fusion with gst. 
Construct P1 encoded for amino acid residues 808 to 824 and included the 
potential  SH3  ligand  domain  RPPPPQP,  and  construct  P2  contained 
amino acid residues 825 to 845, including the second potential SH3 ligand 
domain RPAPAPP.  In construct Pl+2,  both SH3 ligand domains were 
combined by a fusion with amino acid residues 808 to 845. The cDNA for 
each construct was sequenced to rule out any mutations possibly intro- 
duced by PCR. All three fusion proteins, and gst alone, were expressed in 
BL26 cells (Novagen, Madison, WI). To isolate the fusion proteins, bacte- 
ria were disrupted in a French press homogenizer, and gst-fusion proteins 
were allowed to bind to a glutathione matrix (Pharmacia LKB Biotech- 
nology, Piscataway, N J), and eluted with sample loading buffer. As probes 
for the SH3 ligand domain, gst-fusion proteins with either the SH3 do- 
main of Src or Abl (kindly supplied by Dr. Margaret Chao), were isolated 
as described above, and biotinylated with NHS-LC-biotin (Pierce, Rock- 
ford, IL) following the manufacturer's instructions. A  blot of the biotiny- 
luted  Src- and AbI-SH3 fusion proteins was probed  with HRP-labeled 
streptavidin (Pierce), and the level of biotinylation was found to be com- 
parable between the two proteins (not shown). For the actual blot overlay 
experiment, MDC9 gst-fusion proteins were run on a 12% polyacrylamide 
gel and transferred to nitrocelluose. After blocking with 5% dry milk in 
water, the blot was incubated with the biotinylated Src- or AbI-SH3 fusion 
proteins (0.1  p.g/ml),  followed by incubation with HRP-labeled streptavi- 
din. Bound HRP streptavidin was detected by chemiluminescence (ECL, 
Amersham) and exposure of Kodak XAR autoradiography film (New 
Haven, CT). 
Antibodies 
Polyclonal antisera were raised against a gst-fusion protein with the 114 
COOH-terminal  amino acid  residues of the cytoplasmic tail  of mouse 
MDC9 (constructed by PCR as described above for shorter gst-cytotail fu- 
sion proteins). Ribi adjuvant (RIBI Immunochemical Research Inc.) was 
used for immunizations according to established protocols (15). To dem- 
onstrate that the MDC9-cyto IgG  specifically recognize MDC9, we  at- 
tempted to affinity purify antibodies using the gst-fusion protein coupled 
to CNBr-activated Sepharose beads (Pharmacia Biotech). Although sev- 
eral different elution conditions were tested, we were unable to recover 
sufficient amounts of affinity purified IgG. As an alternative control for 
the specificity of the gst-cytotail antibodies, we immunodepleted protein 
A  purified gst-cyto IgG of antibodies reacting with gst alone, or of anti- 
bodies reacting with the gst-cyto fusion protein, using gst or gst-cytotail fu- 
sion protein coupled to CNBr-activated CLAB beads. Immunodepletion 
of IgG reactive with gst or with the gst-cyto fusion protein was confirmed 
by probing Western blots of gst or gst-cyto fusion proteins. 
Western Blot Analysis 
Mouse tissues were  dissected immediately after euthanasia (performed 
according to the guidelines of the American Veterinary Society), and ho- 
mogenized in  10 ml lysis buffer per gram of tissue (1%  NP-40,  1 mM 
EDTA, in PBS and protease inhibitors [7]) using a Polytron homogenizer 
(Kinematica, Littau, Switzerland).  Mouse sperm were isolated from the 
distal cauda epididymis as described (35), washed in PBS, and lysed in ly- 
sis buffer at a concentration of 5 x  107 sperm per ml. NIH 3T3 mouse fi- 
broblasts, and C2C12 mouse myoblasts were lysed at a concentration of 4 
x  106 cells per ml. All lysates were spun at 27,000 g for 30 rain, and the su- 
pernatant was incubated with 1 ml Con A-Sepharose (Pharmacia) per 10 
ml extract for 1 h at 4°C. Bound glycoproteins from all tissues were eluted 
with i  M a-methyl-D-mannose (Sigma Chem. Co., St. Louis, MO) in PBS, 
1%  NP-40, 5  mM EDTA, and protease inhibitors, for 10 rain at 37°C. 
Sample buffer was added to the eluted glycoproteins, and all samples were 
heated to 95°C for 5 min, with or without 50 mM DTT, as indicated. Gly- 
The Journal of Cell Biology, Volume 132, 1996  718 coproteins from mouse sperm, C2C12 mouse myoblasts, and NIH 3T3 fi- 
broblast were eluted by boiling in sample loading buffer. Proteins were 
separated by SDS-PAGE (25), and transferred to nitrocellulose (Schlei- 
cher and Schuell, Keene, NH) using a semidry blotting apparatus (E and 
K, Saratoga, CA). Blotted protein samples were treated as described for 
Western blot analysis (7), except that a  horseradish peroxidase-coupled 
secondary antibody (Promega Biotech, Madison, WI) was used in combi- 
nation with a chemiluminescence  detection system (ECL, Amersham) and 
Kodak XAR autoradiography film. 
Expression  of MDC9 in COS-7 Cells 
The full-length gene for mouse MDC9 was cloned into a pcDNA3 expres- 
sion vector (Invitrogen, San Diego, CA). MDC9 cDNA was transfected 
into  COS-7  cells  (kindly  provided  by  Dr.  M.  Jasin)  using lipofeetin 
(GIBCO/BRL) to obtain a transiently transfected culture. Expression of 
MDC9 in COS-7 cells was monitored by Western blot as described above. 
Cell Surface Labeling 
NIH 3T3 mouse fibroblasts were biotinylated with the nonmembrane-per- 
meable biotinylation reagent NHS-LC-biotin (Pierce) as described in ref- 
erence 22, except that the cells were not lysed and removed from the dish 
until after the 45-min biotinylation reaction on ice, and the subsequent 
quenching of the labeling reaction with 0.1 M glycine. Cell surface iodina- 
tion was performed by incubating a confluent 10-cm tissue culture dish of 
NIH 3T3 fibroblasts with 2 ml PBS containing 120 Ixg lactoperoxidase, 60 
ILl of 0.03% fresh H20  2, and 1 mCi 1251 at 4°C for 10 min. The reaction was 
terminated by addition of 10 ml PBS, 5 mM KI. Extracts of biotin-labeled 
or 125I-labeled  NIH 3T3 cells were immunoprecipitated with MDC9-spe- 
cific antibodies, or control antibodies as described in reference 42. Immu- 
noprecipitated  125I-labeled  material was run on SDS-PAGE, which was 
dried and used to expose Kodak XAR film by autoradiography, whereas 
immunoprecipitated biotinylated material was transferred to nitrocellu- 
lose, probed with horse radish peroxidase-labeled streptavidin, and de- 
tected using a chemiluminscent  detection system as described above. 
Immunofluorescence Staining 
COS-7 cells transfected with MDC9 were grown on 8-well chamber slides 
(Nunc), fixed with 4%  paraformaldehyde, and permeabilized with  1% 
NP-40 in PBS. MDC9-cyto antibodies, or gst-cyto-depleted control anti- 
bodies were added at a concentration of 1:150 in PBS, 0.2% NP-40, fol- 
lowed by a secondary rhodamine-labeled goat anti-rabbit antibody (Boeh- 
ringer Mannheim Corp., Indianapolis, IN). 
Results 
Cloning and Sequencing of Mouse and Human 
MDC9 cDNA 
In  a  previous study, the polymerase chain reaction was 
used to demonstrate that several characteristic sequence 
tags  for cellular disintegrin  proteins  exist  in  the  mouse 
(41). A  cDNA clone of 3,851  bp coding for a full-length 
open reading frame (including sequence tag 16#2 [41]) was 
isolated from a mouse lung cDNA library as described in 
Materials  and  Methods.  The  protein  encoded  by  this 
cDNA was termed MDC9, for metalloprotease disintegrin 
cysteine-rich protein 9. The deduced protein sequence of 
mouse MDC9 contains 845 amino acid residues (Fig. 1 A) 
including  a  predicted  hydrophobic  transmembrane  do- 
main  (Fig.  1 B)  and six potential N-linked glycosylation 
sites. The length of the MDC9 cDNA insert is consistent 
with the size of MDC9 mRNA, which is close to 4 kb as as- 
sayed by Northern blot analysis (Fig. 2). Mouse MDC9 is 
highly related to a partial human cDNA sequence depos- 
ited in  GenBank  (D14665; HUMORF_09).  To compare 
mouse  MDC9  with  the  full-length  human  MDC9,  we 
cloned and sequenced human MDC9 from a cDNA library 
constructed from MDA-MB-468 human mammary epithe- 
lial cancer cells. The longest human MDC9 clone had an 
insert of 3,866 bp with an open reading frame encoding for 
a protein with 819 amino acid residues. 
An alignment of the deduced protein sequences of hu- 
man and mouse MDC9 is shown in Fig. 1 A. The human 
and mouse MDC9 proteins are 82% identical, and contain 
all protein domains that are characteristic of cellular disin- 
tegrins. A  signal sequence is followed by a prodomain, a 
metalloprotease domain, a disintegrin domain, a cysteine- 
rich region, an EGF repeat, a transmembrane domain, and 
a cytoplasmic tail. A comparison of mouse MDC9 with se- 
lected  known  cellular  disintegrin  proteins  revealed  an 
overall sequence similarity of 29% with guinea pig fertilin 
13, 27.5%  with  guinea pig fertilin 0t  (8, 44), 20.5%  with 
mouse MS2 (49), and 20.6% with rat EAPI (34) (data not 
shown, for examples of cellular disintegrin sequence align- 
ments see references 8, 44, 45). 
The hydrophobicity plot of mouse MDC9 indicates that, 
in  addition  to a  hydrophobic transmembrane  domain,  a 
short hydrophobic region is present in precisely the same 
relative position as the predicted fusion peptide of fertilin 
(Fig.  1  B).  The  short  hydrophobic  segment  of both 
mouse MDC9 (not shown) and fertilin a  can be modeled 
as  amphipathic  a  helix (8). However, unlike  guinea  pig 
fertilin a, which is only expressed in testis, both human 
and mouse MDC9 are expressed in all tissues examined by 
Northern blot analysis (Fig. 2). 
Western Blot and Immunofluorescence Analysis 
To analyze the domain organization of MDC9 in mouse 
tissues and cell lines, we raised antibodies against a  gst- 
fusion protein with the cytoplasmic tail of MDC9. For all 
experiments involving MDC9-reactive antibodies, we used 
antibodies raised against the gst-MDC9-cytoplasmic tail, 
and depleted of IgG that bind to the gst moiety only (re- 
ferred to as MDC9-cyto IgG, see Materials and Methods). 
As control IgG, we depleted an identical MDC9 gst-cyto- 
tail  IgG  sample  of all  antibodies  reacting  with  the  gst- 
MDC9-cyto fusion protein. 
Since mouse MDC9 was cloned from a lung cDNA li- 
brary, the initial characterization of MDC9 was performed 
on mouse lung tissue. A Western blot of a mouse lung ex- 
tract  probed  with  MDC9-cyto  IgG  (Fig.  3  A,  lane  1) 
showed a strong band of 84 kD, and two weaker bands of 
115 and 60 kD. As mouse MDC9 is predicted to have six 
N-linked glycosylation sites, it was expected to bind to the 
lectin Con A. In a mouse lung extract depleted of glyco- 
proteins with Con A, the bands of 84 and 115 kD were not 
visible, whereas the 60-kD band was still detectable (Fig. 3 
A, lane 2). Both the 84-kD and 115-kD bands were recov- 
ered from Con A by competitive elution with oL-methyl-D- 
mannose (Fig. 3 A, lane 3). Due to the high cysteine con- 
tent of MDC9 (45 extracellular cysteine residues), reduced 
and  nonreduced MDC9  should  show a  clearly different 
mobility on SDS-PAGE. In a sample of mouse lung glyco- 
proteins analyzed under nonreducing conditions, the MDC9- 
cyto IgG recognized a band of 76 kD, and a weaker ll5-kD 
band (Fig. 3 A, lane 5). Fig. 3 A, lane 4 contains nonre- 
duced mouse lung glycoproteins run  adjacent to the  re- 
duced sample in lane 3. Therefore, proteins in the left part 
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Figure 1.  Comparison of the amino acid sequence of mouse and 
human MDC9. (A) Alignment of the mouse and human MDC9 
amino  acid  sequences  (produced  with  DNA  STAR  MEGA- 
LIGN). A potential signal peptidase cleavage site (39) is marked 
with a large arrowhead. The predicted NH2 termini (44) of indi- 
vidual disintegrin protein domains are indicated by a vertical bar 
and a small horizontal arrowhead above the aligned sequences. 
The metalloprotease consensus sequence is indicated by a  box 
with shaded outlines. The position of the predicted integrin-bind- 
ing sequence TSEC within the disintegrin domain is underlined. 
Potential  N-linked  glycosylation  sites  of  mouse  MDC9  are 
marked with an asterisk. Cytoplasmic proline rich sequences that 
are possibly SH3 ligand domains are boxed and marked P1 and 
P2. (B) Hydrophobicity plots of mouse MDC9 and of guinea pig 
fertilin c~ beginning at the NH2 terminus of the disintegrin do- 
main (produced with DNA strider 1.1 software). A bar marks the 
position of the putative fusion peptide of fertilin et, and of the hy- 
drophobic sequence in MDC9. 
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ysis  of  mouse  and  human 
MDC9 expression.  Northern 
blots of mRNA isolated from 
(A) mouse tissues and prolif- 
erating  C2C12 mouse  myo- 
blasts  (15  ~g  total  RNA 
loaded per lane)  and (B) hu- 
man tissues (Clontech human 
tissue Northern blots 1 and 2) 
were  probed  under  high 
stringency  conditions  with 
the  appropriate  3ZP-labeled 
mouse or human cDNA. The 
mRNA tissue  source is indi- 
cated above each lane. 
of lane  4  are  partially reduced,  which  allows  the  76-kD 
band  (Fig. 3 A, lane 5,  nonreduced  sample) to be traced 
into the 84-kD band (Fig. 3 A, lane 3, reduced sample). An 
identical blot probed with control IgG revealed no binding 
to  the  76-kD  (nonreduced)  or  84-kD  (reduced)  band, 
whereas the ll5-kD band was still visible (Fig. 3 A, bottom 
panel). 
To analyze the expression and processing of MDC9 in 
different mouse tissues  and  cell lines,  a  Western  blot of 
several Con  A-purified mouse tissue  extracts run  under 
reducing conditions was probed with MDC9-cyto IgG, or 
control IgG. In all tissues examined, as well as in mouse 
sperm, NIH 3T3 fibroblasts and C2 muscle cells, an ~84- 
kD protein was observed (Fig. 3 B, top panel).  The relative 
tissue specific expression levels of the MDC9 protein (Fig. 
3 B, top panel) and mRNA (Fig. 2 A) are different, which 
could  result  from  a  different  detergent  extractability  of 
MDC9 depending on the tissue source, or could indicate 
that  MDC9  expression  is  also  regulated  at  the  posttran- 
scriptional level. The slight variations in apparent molecu- 
lar weight might be explained by different carbohydrate 
modifications in different tissues. Both the NIH 3T3 and 
C2C12  (47)  mouse cell lines also contain  a  120-kD band 
that is recognized by MDC9-cyto IgG, but not by control 
IgG, and may represent a small amount of MDC9 precur- 
sor protein. 
As a further confirmation that the 84-kD protein recog- 
nized by MDC9-cyto IgG in mouse tissues and cells is in- 
deed  MDC9,  we  transfected  MDC9  cDNA  into  COS-7 
cells, and compared extracts of MDC9 expressing COS-7 
cells with mouse lung glycoproteins by Western blot (Fig. 
3 C, top panel).  Whereas extracts of nontransfected (Fig. 3 
C, lane 4), or vector-transfected COS-7 cells (Fig. 3 C, lane 3) 
did not contain an 84-kD band recognized by MDC9-cyto 
IgG, extracts of MDC9 expressing COS-7 cells (Fig. 3 C, 
lane 2) contained a protein very similar to the 84-kD gly- 
coprotein in mouse lung (Fig. 3 C, lane 1). A  weaker band 
of 65 kD, which is only visible in MDC9-transfected COS-7 
cells,  may represent  a  proteolytically processed form of 
MDC9.  In an identical blot probed with control IgG the 
84-kD and 65-kD bands were not visible (Fig. 3 C, bottom 
panel).  The control IgG further demonstrate that the 60- 
kD band in lane 1, and the 30-kD bands in lanes 2--4 are 
not specifically recognized by MDC9-cyto IgG. Based on 
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MDC9. Western blots of (A) mouse lung extracts, (B) mouse tis- 
sue extracts,  and (C) extracts of COS-7 cells expressing MDC9, 
were probed with MDC9-cyto IgG prepared as described  in Ma- 
terials  and Methods (upper panel in A-C), or with control IgG 
(lower panel in A-C). Mouse lung samples in A were loaded as 
follows: whole extract (lane 1), extract supernatant (sn) after re- 
moval of glycoproteins with Con A (lane 2), glycoproteins  eluted 
from the Con A pellet (p) with 1 M ~x methyl-o-mannose as de- 
scribed  in Materials and Methods (lanes 3-5). Samples  in lanes 
1-3  were  reduced  before electrophoresis,  whereas  samples in 
lanes 4 and 5 were not. In B the source of Con A purified glyco- 
proteins (mouse lung,  liver,  heart, brain,  testis,  muscle,  sperm, 
C2C12 myoblasts,  and NIH 3T3 fibroblasts)  is indicated  above 
each lane. 10 ixl of Con A purified glycoproteins from each tissue 
(prepared  as  described  in  Materials  and  Methods)  or  mouse 
sperm glycoproteins  from 107 sperm, from 5 ×  105 C2C12 myo- 
blasts, or 5 ×  105 NIH 3T3 fibroblasts  were loaded per lane.  C 
shows a Western blot of mouse lung (lane 1), MDC9 expressing 
COS-7 cells (lane 2), vector-transfected COS-7 cells (lane 3), and 
untransfected COS-7 cells (lane 4). In D, extracts of surface bioti- 
nylated (lanes I and 2), or lzSI-labeled (lanes 3 and 4) NIH 3T3 fi- 
broblasts were immunoprecipitated with MDC9-cyto IgG (lanes 
2 and 3), or with control IgG (lanes 1 and 4). Biotinylated  pro- 
teins were detected with streptavidin HRP as described  in Mate- 
rials and Methods,  and 1251-1abeled proteins were detected by au- 
toradiography. 
the data presented above, we conclude that the 84-kD pro- 
tein recognized on Western blots of mouse tissues under 
reducing conditions is MDC9. 
Considering  that  cellular  disintegrins  are  predicted  to 
play a  role in cell-cell interactions, MDC9 should be de- 
tectable  at  the  cell  surface.  To  confirm  that  MDC9  is 
present at the cell surface, NIH 3T3 fibroblasts were cell 
surface  labeled  by  two  different  methods,  biotinylation 
with the water soluble reagent NHS-LC-biotin, or 1251 iodi- 
nation catalyzed by lactoperoxidase. Labeled NIH 3T3 cell 
extracts were immunoprecipitated with MDC9-cyto IgG, 
or control IgG. Fig. 3 D  shows that a biotinylated protein 
(lane 2), or a 125I-labeled  protein (lane 3) of 84 kD can be 
immunoprecipitated from NIH 3T3 cells with the MDC9- 
cyto IgG, but not with control IgG (Fig. 3 D, lanes I  and 4). 
Although both labeling methods confirm that MDC9 is in- 
deed expressed on the cell surface of NIH 3T3 fibroblasts, 
immunofiuorescence staining of fixed and permeabilized 
NIH 3T3 fibroblasts and C2C12 ceils with the MDC9-cyto 
IgG did not reveal a clear cell surface staining. This result 
may be  due  to  an  insufficient  amount of MDC9  on  the 
plasma membrane for detection, or to obstruction of cyto- 
plasmic epitopes. When immunofluorescence analysis with 
MDC9-cyto IgG was performed on COS-7 cells that were 
transiently transfected with MDC9, a clearly visible stain- 
ing of transfected cells was observed. As shown in Fig. 4 A, 
staining  extended  into  the  cell  boundary  and  into  pro- 
cesses emanating from the labeled cell, consistent with the 
staining pattern of a plasma membrane protein. Nontrans- 
fected  cells showed  very little  staining  with  MDC9-cyto 
IgG (Fig. 4 C), and no staining of either transfected (Fig. 4 B) 
or nontransfected cells (not shown) incubated with control 
IgG was apparent. These results suggest that, by indepen- 
dent assays, MDC9 is expressed at the cell surface of NIH 
3T3 fibroblasts and of COS-7 ceils. 
Potential Src Homology 3 Ligand Domains 
The sequence of the cytoplasmic tail of human and mouse 
MDC9 is relatively rich in proline residues, including two 
short  sequences  that  closely resemble the  consensus  for 
Src homology 3 (SH3) ligand domains (Fig. 1 A) (2, 12, 26, 
27,  38). To provide preliminary evidence that these pro- 
line-rich sequences might function as SH3 ligands, we blot- 
ted expressed gst-fusion proteins containing different por- 
tions  of the  MDC9  cytoplasmic tail  onto  nitrocellulose. 
Gst-chimeras with  the  SH3 domains  of Src or Abl were 
used to overlay blotted MDC9 gst-fusion proteins. Fig. 5, 
bottom panel, shows a Ponceau S stained blot of expressed 
MDC9 gst-fusion proteins. Fig. 5, lanes 1 and 5 contain a 
gst-fusion protein with both potential SH3 ligands of the 
MDC9 cytoplasmic tail, lanes 2 and 6 contain a gst-fusion 
with only the first, and lanes 3 and 7 with only the second 
proline-rich sequence, whereas lanes 4  and 8  contain the 
gst protein alone. In Fig. 5, upper panel, lanes 1-4 of the 
same blot are overlayed with a  biotinylated Src SH3-gst- 
fusion protein, which bound best to the construct contain- 
ing both potential SH3 ligand domains. Comparably weaker 
binding  of Src SH3-gst to  either  construct  with just  one 
proline-rich sequence was evident, while Src SH3-gst did 
not  bind  to  gst  alone.  The  Abl  SH3  domain,  which  is 
known to bind different ligands than the Src SH3 domain 
(2, 12, 26) (see below), did not bind to the MDC9 cytotail, 
gst-fusion proteins (Fig. 5, lanes 5-8, upper panel), consis- 
tent with a  distinct binding specificity of the MDC9 SH3 
ligand domains for different SH3 domains. 
Discussion 
The  present  study describes  the  cloning  and  initial  bio- 
chemical characterization of the cellular disintegrin MDC9 
(metalloprotease/disintegrin/cysteine-rich protein 9).  Cel- 
lular disintegrins are a  recently recognized protein family 
with at least 17 members in the mouse (16, 41, 45, 48, 49) 
(Weskamp, G., and C. Blobel, unpublished sequence tags), 
and a growing number of members in other species (4, 11, 
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plasmic tail sequences. Gst-fusion proteins with different parts of 
the mouse MDC9 cytoplasmic tail were blotted onto nitrocellu- 
lose and stained with Ponceau S (lower panel). Blotted proteins 
were probed with biotinylated gst-fusion proteins with the SH3 
domains  of Src (upper panel, lanes  1-4)  or Abl (upper panel, 
lanes 5-8). In both panels, lanes 1 and 5 contain a gst-fusion pro- 
tein with both proline-rich MDC9 cytoplasmic sequences (P1 and 
P2, bold type in Fig. 1 A), lanes 2 and 6 contain a fusion-protein 
with only P1, and lanes 3 and 7 with only P2. Lanes 4 and 8 con- 
tain gst as a control. 
Figure  4.  Immunofluorescence  staining  of  MDC9  expressing 
COS-7 cells. MDC9 expressing COS-7 cells were fixed with 4% 
paraformaldehyde, permeabilized with 1% NP-40, and incubated 
with MDC9-cyto IgG (A), or with control IgG (B), at a 1:150 di- 
lution.  Fixed  and  permeabilized  vector-transfected  (control) 
COS-7 cells incubated with MDC9 cytotail antibodies are shown 
in C. Bound antibodies were visualized with a Zeiss Axiophot mi- 
croscope  after  addition  of rhodamine-coupled  secondary anti- 
bodies. 
21, 32-34, 46). Since the currently best characterized cellular 
disintegrin, the guinea pig sperm protein fertilin, plays a crit- 
ical role in sperm-egg membrane binding and fusion (29, 35), 
it has been proposed that  other cellular  disintegrins  also 
mediate cell--cell or ceil-matrix interactions (6, 41, 46). 
Both human and mouse MDC9 contain all protein  do- 
mains that are characteristic  for cellular disintegrins  (see 
above, and Fig. 1 A). Within the metalloprotease  domain 
of MDC9, the zinc-binding consensus sequence HEXXH 
is in a conserved position compared to related snake venom 
metalloproteases (6, 44). Therefore, we predict that MDC9 
can function as a metalloprotease, which may be regulated 
through a  cysteine switch mechanism (5, 6, 44). The pre- 
dicted cleavage site between the MDC9 pro- and metallo- 
protease  domain contains  four consecutive  arginine  resi- 
dues,  and thus  a  substrate  sequence  for serine  proteases 
such as the pro-protein convertase furin (10, 13, 40). Furin 
is  known  to  cleave  and  activate  another  prometallopro- 
tease,  stromelysin, between  the prodomain and the cata- 
lytically active domain (31). 
The  disintegrin  domain  of MDC9  is  highly related  to 
RGD-type snake venom disintegrins (6, 8, 14). An impor- 
tant distinction is that, like all other presently reported cel- 
lular  disintegrins,  MDC9  does  not  contain  an  RGD  se- 
quence in the same relative position  as the snake venom 
disintegrin RGD. The sequence found instead of the RGD 
in both mouse and human MDC9 is TSE, which is directly 
followed by an additional  cysteine residue  not present  in 
RGD-type  snake  venom disintegrins,  but  is  found in  all 
other cellular disintegrins.  Several integrins  are known to 
bind to sequences other than RGD (20), and, although the 
effect of the additional cysteine residue on the folding and 
function of cellular disintegrins remains to be established, 
the sequence replacing the RGD in cellular disintegrins is 
predicted to function as an integrin ligand (6, 8). This hy- 
pothesis  is supported  by fertilization  studies,  where  pep- 
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quence of fertilin t3 were shown to block sperm-egg fusion, 
whereas scrambled control peptides did not (3, 29). Fur- 
thermore, mouse fertilization can be blocked by antibod- 
ies against the integrin ot6131 (3). 
The cysteine-rich region of MDC9 that follows the disin- 
tegrin  domain  includes  a  hydrophobic  sequence  in  the 
same position, relative to conserved cysteine residues, as 
the predicted fusion peptide of guinea pig fertilin et (8). 
Like the fusion peptide of fertilin et, the hydrophobic re- 
gion of MDC9 can be modeled as an amphipathic helix, 
which raises the question whether MDC9 could also be a 
membrane fusion protein. However, since expression of 
MDC9 is not restricted to tissues involved in cell-cell fu- 
sion, but instead is ubiquitous, any potential function of 
MDC9 in cell-cell fusion would have to be strictly regu- 
lated. Alternatively, this hydrophobic region may serve a 
different function in MDC9, such as a role in protein fold- 
ing or protein-protein interactions. 
The most notable feature of the cytoplasmic sequences 
of mouse and human MDC9 are two conserved potential 
SH3 ligand domains (RPPPPQP, and RPAPAPP), which 
are  similar  to  the  Src  SH3-binding  consensus  sequence 
RPLPXXP (2, 12, 26). Consistent with the predicted speci- 
ficity of the MDC9 SH3 ligand domains, a biotinylated Src 
SH3  domain  interacts  with  the  MDC9  proline-rich  se- 
quences, whereas the Abl SH3 domain does not (2). The 
binding of Src SH3 to MDC9 proline-rich sequences sug- 
gests that  these  may indeed function as  SH3 ligand  do- 
mains,  although  it does not imply that Src is the  actual 
ligand  in  vivo, since  a  leucine in  position 3  is  found in 
known Src-SH3 ligand domains (2, 38). SH3 domains are 
present in cytoskeletal proteins and in signaling molecules 
(30), and it is tempting to speculate that MDC9 may inter- 
act with cytoplasmic proteins. At least two other cellular 
disintegrins, mouse MS2 (49) and meltrin a  (48), also con- 
tain similar cytoplasmic proline-rich sequences. 
In characterizing MDC9, it was important to determine 
if its metalloprotease and/or disintegrin domains are mem- 
brane  anchored.  The  functional  implications  are  that  a 
plasma membrane-anchored disintegrin domain could have 
a role in cell--cell interactions, whereas a proteolytically re- 
leased disintegrin domain might function as a matrix-asso- 
ciated integrin ligand, or as a soluble integrin ligand which 
could  possibly  disrupt  cell-cell or  cell-matrix  adhesion 
(41).  Likewise,  a  membrane-anchored  metalloprotease 
domain might have other roles and substrates than a solu- 
ble  metalloprotease.  In  all  mouse tissue  or cell extracts 
that were analyzed by Western blot with MDC9-cyto IgG, 
a glycoprotein of close to 84 kD was revealed, indicating 
that MDC9 is not subject to different proteolytic process- 
ing events in these tissues. Because the predicted molecu- 
lar weight of mouse MDC9 (after removal of the signal se- 
querice) is 89, the apparent molecular weight of 84 suggests 
that,  in most tissues  and  cells,  MDC9  contains  a  mem- 
brane-anchored metalloprotease and disintegrin domain. 
MDC9  could  be  cell  surface  biotinylated  and  125I-iodi- 
nated  on  NIH  3T3  mouse  fibroblasts,  indicating  that 
MDC9 is present on the cell surface of these cells. Further- 
more, the immunofluorescence staining pattern of MDC9 
expressing COS-7 cells was consistent with that of a cell 
surface protein. 
In  summary,  we  have  isolated  and  sequenced  cDNA 
clones encoding mouse and human MDC9,  a widely ex- 
pressed  cellular disintegrin.  The cytoplasmic domain  of 
MDC9  contains potential SH3 ligand  domains  and  may 
play a role in interactions with the cytoskeleton or with in- 
tracellular  signaling  molecules.  The  apparent  molecular 
weight of MDC9 in different mouse tissues and cell lines 
suggests that it contains both membrane-anchored disinte- 
grin  and  metaUoprotease domains,  and  might  therefore 
have a dual function as a metalloprotease and/or integrin 
ligand. We anticipate that further study of this widely ex- 
pressed cellular disintegrin protein will lead to a better un- 
derstanding of the role of members of this newly recog- 
nized protein family in cell-cell interactions. 
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